188 related articles for article (PubMed ID: 27236532)
1. Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry.
Nijenhuis CM; Lucas L; Rosing H; Jamieson G; Fox JA; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():1-10. PubMed ID: 27236532
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II.
Nijenhuis CM; Lucas L; Rosing H; Huitema ADR; Mergui-Roelvink M; Jamieson GC; Fox JA; Mould DR; Schellens JHM; Beijnen JH
Invest New Drugs; 2017 Aug; 35(4):478-490. PubMed ID: 28138829
[TBL] [Abstract][Full Text] [Related]
3. Validation of high-performance liquid chromatography-tandem mass spectrometry assays quantifying omacetaxine mepesuccinate and its 4'‑des-methyl and cephalotaxine metabolites in human plasma and urine.
Nijenhuis CM; Lucas L; Rosing H; Schellens JH; Beijnen JH; Gorman SH; Burke SM; Campbell DA; Chapple MW; Yousey TH; Mulvana DE
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():152-9. PubMed ID: 26319804
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine.
Roosendaal J; Wang K; Rosing H; Lucas L; Gebretensae A; Oganesian A; Schellens JHM; Beijnen JH; Lin ZJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():132-141. PubMed ID: 30754019
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of plasma and urine 3-hydroxyglutaric acid, after separation from 2-hydroxyglutaric acid and other compounds of similar ion transition, by liquid chromatography-tandem mass spectrometry for the confirmation of glutaric aciduria type 1.
Simon GA; Wierenga A
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():101-110. PubMed ID: 30218917
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of LC-MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices.
Dubbelman AC; Rosing H; Thijssen B; Gebretensae A; Lucas L; Chen H; Shumaker R; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():25-34. PubMed ID: 22309776
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying olaparib in human plasma.
Nijenhuis CM; Lucas L; Rosing H; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():121-5. PubMed ID: 24145016
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of imigliptin and its three metabolites in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.
Liu Y; Liu D; Liu H; Song H; Song L; Yao X; Wu F; Shu C; Ma X; Zhou H; Jiang J; Hu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():300-12. PubMed ID: 26355270
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine.
van Andel L; Zhang Z; Lu S; Kansra V; Agarwal S; Hughes L; Tibben MM; Gebretensae A; Rosing H; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():14-21. PubMed ID: 27898364
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine.
Dubbelman AC; Tibben M; Rosing H; Gebretensae A; Nan L; Gorman SH; Robertson P; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():92-100. PubMed ID: 22426286
[TBL] [Abstract][Full Text] [Related]
11. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
12. A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study.
Yao X; Song L; Liu Y; Wang H; Liu J; Jiang J; Liu D; Hu P
J Pharm Biomed Anal; 2019 Mar; 166():20-29. PubMed ID: 30599278
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantification of MTC-220 and its metabolites in beagle dog plasma by liquid chromatography-tandem mass spectrometry.
Liu X; Zhao M; Mi J; Liu Z; Hu J; Sheng L; Wang B; Li D; Yang S; Li Y
J Pharm Biomed Anal; 2014 Oct; 99():1-7. PubMed ID: 25036904
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
[TBL] [Abstract][Full Text] [Related]
15. An HPLC-MS/MS method for simultaneous determination of the active metabolites of febuxostat (67M-1, 67M-2 and 67M-4) in human plasma.
Xie H; Wang Z; Deng K; Jiang X; Wang L; Lv G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 970():24-30. PubMed ID: 25222745
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
17. High performance liquid chromatography-tandem mass spectrometric assay of dexmedetomidine in plasma, urine and amniotic fluid samples for pregnant ewe model.
Cui Z; Chow DS; Wu L; Lazar DA; Rodrigo R; Olutoye OO; Olutoye OA
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 961():13-9. PubMed ID: 24854710
[TBL] [Abstract][Full Text] [Related]
18. Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
Cardoso E; Mercier T; Wagner AD; Homicsko K; Michielin O; Ellefsen-Lavoie K; Cagnon L; Diezi M; Buclin T; Widmer N; Csajka C; Decosterd L
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():124-136. PubMed ID: 29544202
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry.
Stokvis E; Nan-Offeringa LG; Ouwehand M; Tibben MM; Rosing H; Schnaars Y; Grigat M; Romeis P; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2004; 18(13):1465-71. PubMed ID: 15216507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
